MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,913,000 | +35.7% | 98,058 | +3.5% | 0.02% | +27.8% |
| Q1 2016 | $4,356,000 | +59.7% | 94,729 | +67.9% | 0.02% | +50.0% |
| Q4 2015 | $2,727,000 | +25.3% | 56,420 | +10.2% | 0.01% | +33.3% |
| Q3 2015 | $2,177,000 | +35.8% | 51,220 | +264.8% | 0.01% | +50.0% |
| Q2 2015 | $1,603,000 | -6.1% | 14,040 | +6.1% | 0.01% | 0.0% |
| Q1 2015 | $1,708,000 | +3.3% | 13,230 | -20.3% | 0.01% | 0.0% |
| Q4 2014 | $1,654,000 | -30.7% | 16,600 | -31.2% | 0.01% | -33.3% |
| Q3 2014 | $2,387,000 | +12.2% | 24,140 | -12.6% | 0.01% | +28.6% |
| Q2 2014 | $2,128,000 | +15.1% | 27,610 | -3.9% | 0.01% | 0.0% |
| Q1 2014 | $1,849,000 | +19.7% | 28,730 | +18.7% | 0.01% | +16.7% |
| Q4 2013 | $1,545,000 | +10.0% | 24,210 | +3.3% | 0.01% | +20.0% |
| Q3 2013 | $1,404,000 | +352.9% | 23,430 | +271.3% | 0.01% | +400.0% |
| Q2 2013 | $310,000 | – | 6,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |